The dominant neomycin resistance gene (neo R) was introduced into the genome of the myeloproliferative sarcoma virus (MPSV), a replication-defective retrovirus carrying the mos oncogene. The resulting selectable neoR-MPSV virus did not lose its acute transforming property, unlike the results of attempts by other groups to insert marker genes into oncogenic viruses. NeoR-MPSV DNA was used to generate infectious virus by transfection followed by rescue with Friend or Moloney murine leukaemia virus. Infection of fibroblasts with this virus resulted in morphologically transformed cells which were resistant to the neomycin analogue G418. Segregation of the two functions (transformation and G418 resistance) was not observed in more than 500 independent viral transfers to fibroblasts. Furthermore, neoR-MPSV retained the leukaemogenesis-inducing properties of the wild-type virus. Myeloproliferation and G418-resistance transfer did not segregate after passage in mice.
INTRODUCTION
Retroviruses are naturally occurring eukaryotic cell transducing vectors, and thus provide an ideal way of introducing foreign genes into eukaryotic cells (Shimotohno & Temin, 1981 ; Tabin et al., 1982; Perkins et al., 1983; Lewis et al., 1984; Miller et al., 1984; Williams et al., 1984) . Their ability to integrate stably into host chromosomal DNA and their efficient transmission to a wide variety of cell types make them a gene transfer system which is superior to the calcium phosphate method of transfection (Graham & van der Eb, 1973; Wigler et al., 1977 Wigler et al., , 1978 . Furthermore, virus-introduced genes express 10-to 50-fold higher levels of transcription compared to those introduced by DNA-mediated gene transfer .
The introduction of selectable markers into the retrovirus genome greatly extends the utility of such a transducing vector, facilitating the screening and isolation of infected cells. Several groups have reported the generation of selectable, infectious retroviruses by recombination with a marker gene, either regulated by its own promoter or by the functional promoter within the retrovirus long terminal repeats (LTRs). When highly transforming retroviruses were used, however, the resultant recombinant virus often had lost its transforming activity (Joyner & Bernstein, 1983a, b; Tarpley & Temin, 1984) . Only two viral oncogenes, Ha-ras (Wei et al., 1981) and src (Tarpley & Temin, 1984) , have been combined with a selectable recessive marker gene, the herpes simplex virus thymidine kinase gene (HSV-tk), to generate vectors which stably co-express the transforming function and the selectable marker gene.
We describe in this work the construction of a dominant, selectable transforming retrovirus vector by the introduction of the transposon 5 (Tn5) neomycin resistance (neo g) gene into the defective pol gene of the myeloproliferative sarcoma virus (MPSV). MPSV is a unique member of the Moloney murine sarcoma virus (Mo-MSV) family which not only transforms fibroblasts in vitro and induces sarcomas in adult mice, but also causes extensive changes in the haematopoietic system (Ostertag et Transfected cell lines or established non-producer cell lines were superinfected with helper virus, resulting in release of infectious pseudotypes that confer resistance to G418, a neomycin analogue, to infected fibroblasts without loss of mos expression. A series of experiments was designed to estimate the segregation frequency of the two genes on passage of the modified virus to fibroblasts and to haematopoietic cells of the mouse.
METHODS
Cell lines. Cell lines used in these studies and referred to in the figure were as follows: RAT1, NIH 3T3 and NRK (normal rat kidney) cells were used for transfection and infection experiments. RAT1 and NRK are rat fibroblast cell lines Topp, 1981) . N IH 3T3 cells were obtained from Dr R. A. Weinberg. Cell line 643/22N is a clone of SCI cells, which releases high titres of twice-cloned Friend helper virus (F-MuLV) (Bilello et at., 1980; Ostertag et al., 1980) . Cell line Mo-MuLV CI 2 c, provided by R. Jaenisch, is a NIH 3T3 cell clone that releases high titres of cloned Mov-3 Mo-MuLV. All cell lines were grown in modified Eagle's medium supplemented with 10~o foetal calf serum.
Plasmids. The construction of the plasmid vector neoR-MPSV used for transfection experiments is described in Results. The neomycin resistance gene from pACYC neo R (Chang & Cohen, 1978) was ligated into the wild-type MPSV plasmid p18-663 . Plasmid pAG60 (Colb~re-Garapin et al., 1981) , which contains the HSV-tk transcription controls and the neo R coding region, was used as control for transfection experiments (see below), as well as for a nick-translated probe. Plasmid pmSI (Oskarsson et al., 1980) containing the c-mos gene was used to detect mos homologous sequences. Large-scale plasmid preparations were purified by CsCl-ethidium bromide density gradient centrifugation.
TransJbction experiments. These were performed as described previously (Wigler et al., 1978; Kollek et al., 1984) . A calcium phosphate precipitate prepared with 0.1 ~tg to 1-0 ~tg MPSV plasmid DNA in the presence of 30 p,g of high molecular weight DNA from calf thymus was added to 5 x 105 cells/T75 flask. For selection ofneo R colonies, cells were grown in medium containing 400 ~tg/ml G418 (Gibco). Cells resistant to the antibiotic appeared 2 to 4 weeks after DNA-mediated gene transfer.
Virus rescue and virus assays. The neo R colonies were superinfected with F-MuLV or Mo-MuLV and the titre of infectious neoR-MPSV virus was determined by measuring reverse transcriptase activity, fibroblast focus formation (as £f.u.) and spleen focus formation (s.f.f.u.). The infectious virus was obtained either directly from spleens or from cell culture supernatants . In some experiments virus from tissue culture supernatants was concentrated 10-to 100-fold with a DC hollow fibre apparatus followed by a second step of concentration and dialysis with an Amicon type XM300 membrane . The reverse transcriptase activity was determined using a simplified procedure described earlier (Pragnell et al., 1977) , and corrected for variations by using viral supernatant of Friend cells as a standard. The fibroblast focus formation assay was carried out with N RK or RAT1 fibroblasts . Spleen focus formation was assayed by injecting the filtered viral supernatant into the lateral tail vein of DBA/2J mice. Serial viral dilutions were made and three mice were injected with 0-5 ml of viral suspension for each virus concentration. Spleens were removed, fixed, and spleen foci were counted 16 and 21 days later .
Southern and Northern blot analysis. Cellular DNA was extracted as described previously (Miller et al., 1984) : DNA samples were digested with restriction endonucleases (Bethesda Research Laboratories) under the conditions recommended by the supplier and separated on a 0.8 ~ agarose gel in TEA buffer (40 mM-Tris-OH, 20 raM-sodium acetate, 20 mM-NaCI, 2 mM-EDTA, pH 8. l). The gels were treated and the DNA was transferred to Gene Screen (New England Nuclear) filters (Southern, 1975) . The filters were hybridized to 3zp-labelled nicktranslated mos or neo R probes (see Plasmids).
Total cellular RNA was extracted (Auffray & Rougeon, 1980) , glyoxylated and subjected to agarose gel electrophoresis (20 ~tg/slot) (McMaster & Carmichael, 1977) . The RNA was transferred to Gene Screen as recommended by the supplier and hybridized to 32p-labelled mos and neo R probes. 
RESULTS
The neoR-MPSV vector As determined by restriction enzyme analysis , hybridization, and partial DNA sequencing (Stacey et al., 1984) , MPSV contains the intact gag gene of Mo-MuLV and approximately 2.5 kb of the 3' pol gene sequences (including the 3' splice acceptor consensus sequences). Approximately 200 bases of the env gene remain, interrupted by introduced c-mos sequences. A 1.5 kb BgllII-BamHI fragment of Tn5 (Jorgensen et al., 1979) , containing the neo R coding region but not the eukaryotic transcription signals from the plasmid pACYC neo R, was inserted into the first BamHI site of the defective MPSV gene for reverse transcriptase (pol) (Fig. 1) . The neo R gene confers resistance to the antibiotic G418 in eukaryotes (Chang & Cohen, 1978) . Under conditions in which transcription of the introduced neo R gene is initiated from the viral LTR, we postulated that translation of the protein would be possible in a manner similar to that ofthepolgene of Mo-MuLV (Weiss et al., 1982) . It was further assumed that an insert in the already defective pol gene would not interfere with the expression of the mos oncogene.
Transfer of the neoR-MPSV DNA to fibroblasts and virus rescue
Experiments were carried out to answer the following questions. (i) Is the neo R gene expressed in the frame of the MPSV genome? (ii) Is MPSV still expressing mos fibroblast-transforming functions? (iii) Are haematopoietic cell-transforming functions still being expressed ? (iv) Do the two genes (mos and neo R) segregate and what is the frequency of segregation?
Unlike other spleen focus-forming virus isolates (Ostertag & Pragnell, 1982) , MPSV also transforms fibroblasts, thus allowing expression of both neo R and the mos oncogene to be tested directly in fibroblasts. RAT1 and NIH 3T3 fibroblasts were utilized for transfection experiments with either neoR-MPSV plasmid DNA or pAG60 DNA as a parallel control. Selection was applied 2 days after transfection by adding 400 ~tg/ml G418 to the culture medium. Colonies of resistant cells were counted 3 weeks after initiation of selection. Similar numbers of resistant colonies were obtained at equal molarities of each plasmid DNA (approx. 200 colonies/0.1pmol), indicating that the potential for neo R expression was not altered by its inclusion in the MPSV genome. Furthermore, all resistant colonies obtained on transfection with neoR-MPSV DNA appeared transformed, in contrast to the resistant colonies obtained from control pAG60 DNA transfer experiments. This was to be expected if viral transforming functions (mos gene expression) and G418 resistance are expressed coordinately in the same viral genome.
Several primary and independently isolated neoR-MPSV-transfected RAT1 clones were infected with F-MuLV. Released virus was tested for focus formation on NRK fibroblasts. Clone RAT1-4Mneo had the highest titre of focus-forming virus (2 × 105 to 2 × 106 f.f.u./ml of tissue culture supernatant) and also proved to be unusually stable. Virus of Ratl-4Mneo cells was therefore used exclusively to obtain secondary non-producer cell lines.
Generation of non-producer cell lines: transformed cells are resistant to G418
Cell lines transfected by neoR-MPSV were very often unstable and contained a variable copy number and size of the newly introduced genes and see below) . To obtain cell lines with a single, stably integrated viral copy, virus from RAT1-4Mneo cells at limiting dilutions was used to infect NRK cell lines. Foci were picked and cloned in agar. Cloned cell lines were tested for virus release and non-producer cell lines were retained. All transformed non-producer clones proved to be resistant to G418.
The clonability of transformed cloned cell lines in the presence of G418 was determined in order to test whether cells selected on the basis of their transformed phenotype expressed the neo R gene at sufficient levels to enable growth under G418 selection or whether variant cells were subsequently generated in which the expression of the neo R gene had been suppressed when selective pressure was not employed. Because normal NRK cells cannot be cloned efficiently in agar, the transformed cell clone NRK no. 10 Ag2 obtained by infection with cloned wild-type MPSV virus was used as control. In the presence of 400 ~tg G418/ml medium, no resistant colonies were obtained with the control cell line, whereas all of the non-producer cell clones obtained by infection with neoR-MPSV proved to be resistant. The cloning efficiency with G418 selection in medium was comparable to that without G418 selection in agar (Table 1) . These data thus indicate that the two functions, G418 resistance and mos-mediated transformation, were not segregating. 
Southern and Northern blot analysis of non-producer cell lines transfected or infected by neoR-MPS V
High molecular weight D N A of the clone R A T 1-4Mneo obtained by transfection and of five neoR-MPSV non-producer N R K cell lines obtained by infection with virus from cell clone RAT1-4Mneo was analysed by Southern blot hybridization to determine copy number and size of integrated neoR-MPSV genomes. The restriction enzyme SstI cut within the retrovirus LTR, generating a neoR-MPSV-specific fragment of 8.1 kb ( Fig. 1 and 2) . A n SstI digest of clone RAT1-4Mneo showed multiple full-length as well as altered copies of the neoR-MPSV genomes, whereas all clones obtained by infection contained a single unaltered copy. Clone no. 12 contained an additional altered copy. All full-length bands hybridized to both the mos and neo probes.
Total cellular R N A from RAT1-4Mneo clone no. 23 was isolated and subjected to Northern blot analysis. The filter was hybridized to a mos probe and subsequently re-hybridized to a neo R probe. A full-length band of approx. 8-0 kb was detected with both probes and two additional * This is the average titre from four independent experiments. Wild-type virus is of cell clone NRK no. 10 Ag2, a non-producer cell clone infected with F-MuLV (see Table 1 ).
faint bands of about 4.2 and 2.6 kb were detected with the mos probe. The latter band was the size expected of the mos transcript if either the env splicing sites of Mo-MuLV were employed or, alternatively, if the mos mRNA was initiated by its own promoter (Narayanan et al., 1984 ) (see Discussion). The amount of subgenomic, mos-specific RNA was not discernibly less than observed with wild-type MPSV.
Stability of the neoR-MPSV virus at endpoint dilution
To examine more closely the stability of the neoR-MPSV virus, titres obtained by assaying for fibroblast transformation and those obtained by assaying for G418-resistance transfer were compared. If segregation of the functions was occurring, higher titres for either G418 transfer or for fibroblast transforming activity (f.f.u.) would be expected.
The results indicated that titres calculated by counting colonies resistant to G418 were usually threefold lower than those obtained by measuring foci of transformed cells for a given neo R-MPSV virus suspension (Table 2 ). It could be envisaged that differences in f.f.u, titre for the two functions were due to epigenetic repression of one gene due to expression of a second, selected gene. This has recently been reported by Emerman & Temin (1984) for another retrovirus vector expressing two marker genes. A more accurate estimate of the degree of segregation would therefore be obtained by testing expression of both functions in individual clones obtained at endpoint dilution of virus. Ten colonies selected for resistance to G418 were isolated; all cells appeared transformed and were still resistant to G418. Reciprocally, transformed colonies were picked and exposed to G418. Although growth was initially slow in some clones, all transformed cell clones contained a large proportion of G418-resistant cells. Titration curves of G418 tolerance reflected a large variance from cell to cell on initial exposure (data not shown). This accounted for the initial slow growth of cells under G418 selection and the lower titres found on the basis of G418-resistant colonies. As expected, no G418-resistant colonies were obtained with wild-type MPSV virus suspension and the transformed clones (foci) obtained contained no G418-resistant cells. These experiments again indicated linkage and lack of segregation of the mos and neo R functions.
Stability of the neoR-MPSV as estimated by endpoint dilution of virus and cells
RAT1 cells were exposed to various dilutions of virus (Table 3) , trypsinized within 3 h after infection to prevent secondary virus infection, and subsequently cloned in 96-well plates at different cell concentrations. This approach increased the probability that the progeny of one cell infected by one or several viral particles were analysed. Cloning efficiency of an uninfected parallel control culture was determined to be 30 to 44~, as calculated by using the Poisson distribution. No colonies developed with control cells under G418 selection. One, three or ten cells/150 ~tl of medium were exposed to different virus dilutions and maintained in two 96-well plates per virus dilution and cell number. One of the two series was exposed to G418. Selection was started 4 days after infection to ensure sufficient expression of the neo R gene. Resistant cell colonies were scored 12 days later ( were infected with 2.5 mlofvirussuspensionofcellclone 1-4Mneosuperinfected withFMuLV and diluted at different cell concentrations (one and three cells/well) in 96-well plates after 3 h. Colonies were scored 2 weeks after infection. Colony numbers were corrected by Poisson distribution analysis. Note: The titres as calculated using either the transformed phenotype (8.6 × 106/ml)or, alternatively, G418 resistance (6"8 x 106/ml) are rather similar in the linear range of virus dilutions (< 1/125). They do not differ by the same factor of two or three as in experiments with endpoint dilution on excess cells (Table 2 ). There may be two reasons for this: (i) G418 selection was done 2 days post-infection in experiments shown in Table 2 but at 4 days post-infection in these experiments; (ii) progeny of single cells could be analysed and cell colony loss minimized for experiments presented here.
t Expected colonies of uninfected RAT1 cells/well seeded at the same dilution factor in control experiments (data not shown).
:~ Selection with G418 4 days after infection. § Calculated virus titre based on resulting colonies/well. 4 x 106 f.f.u./ml (estimated by endpoint dilution on excess fibroblasts), an average of 1-04 colony-forming G418-resistant cells/well was obtained, as opposed to 1.3 colony-forming cells when no selection was applied. This indicated that G418 resistance had been transferred to the majority of cells after infection with the neoR-MPSV virus. This was close to the maximum obtainable value, as infection with a 1:25 virus dilution still showed 0-73 colony-forming resistant cells/well, corrected for double and multiple cell numbers using the Poisson distribution. Using these data, we calculated the titre of neo R transfer units (Table 3) . At the endpoint dilution of virus (dilution of 1:125 and lower) the calculated titre was 6 x 106 to 9 x 106/ml. This represents a two-to fourfold higher titre than was estimated by endpoint dilution of virus on excess cells (see Table 2 ). More importantly, all of the 326 (total) colonies which were resistant to G418 also contained transformed cells. G418-resistant colonies which appeared to have only a few morphologically recognizable transformed ceils were passaged. All of these showed a higher percentage of transformed cells upon passage. The reverse experiment was done with the second series of 96-well plates, in which cells were not treated with G418. The number of transformed colony-forming cells was determined 14 days after infection. The titres of transforming neoR-MPSV virus were comparable to those obtained using G418 resistance as a parameter (Table 3) . The cells were then re-fed with new medium containing 400 ~tg G418/ml to determine whether transformed colonies were also resistant to G418. Fourteen days later, colonies were tested for survival. Only 154 colonies could be tested because of bacterial contamination, but all were G418-resistant. Analysed together, these data indicate a segregation rate of less than 1/500 per infectious viral particle suspension for the two marker genes (see also Discussion).
Leukaemogenesis of the neoR-MPSV virus
The previous results demonstrated that neoR-MPSV virus transferred both G418 resistance and fibroblast transformation and that segregation, if it occurred, was very infrequent. Alteration of the viral genome could, however, conceivably have altered its second transforming action, that on haematopoietic cells. Therefore, six DBA/2J mice were injected intravenously for each dilution of a fivefold serial dilution of neoR-MPSV virus. Mice infected at high virus concentrations developed the typical myeloproliferative syndrome with excessive proliferation of all cells of the myeloid linkage. The disease developed, however, more slowly than with wildtype virus. Spleen foci induced by neoa-MPSV were therefore counted at days 18 to 21 postinjection, compared to wild-type MPSV virus where foci were counted 14 to 16 days postinjection. The ratio of spleen focus-forming units to fibroblast focus-forming units was only slightly lower with the neoR-MPSV virus than with the molecularly cloned wild-type virus (Table  4) .
The integrity of the neoR-MPSV virus after passage through mice was determined. Virus of spleen homogenates from mice was used to infect NRK cells and titres were counted when selection with G418 was made (0.5 x 106) and compared with the titres obtained after selection for the transformed phenotype (4.2 x 106). Once again, individual clones were analysed to obtain a more accurate estimate of segregation. Ten transformed clones were picked and were grown in the presence of G418; conversely, ten G418-resistant clones were tested for transformation. All clones checked expressed both phenotypes.
DISCUSSION
Retrovirus oncogenes (v-onc) were originally considered to be peculiar features of oncogenic retroviruses, and of only theoretical interest for the study of malignant transformation in humans. This conclusion has changed radically during the last few years and it is now generally accepted that activated or mutated c-onc genes are prerequisites for generating 'spontaneously' arising transformed cells in humans or vertebrates (Der et al., 1982; Parada et al., 1982; Santos et al., 1982) .
Direct studies of the transformation process of the oncogenes have been hampered by many obstacles: first, it is difficult to culture and identify target cells; second, introduced genes are not expressed in all cells; third, inherent differences exist between the oncogenes found in the cellular genome and in the transforming retrovirus, making interpretations difficult. We have characterized here a retrovirus vector, neoR-MPSV, that overcomes some of these difficulties.
The use of selectable dominant markers in conjunction with an oncogene-carrying retrovirus vector allows selection of infected cells immediately after transfer of the oncogene by elimination of cells that have not incorporated the transduced genes. With a few exceptions (Wei et al., 1981 ; Tarpley & Temin, 1984) , the alteration in the genome of any transforming retrovirus by introduction of marker genes was connected with unexpected difficulties: most such constructs are either highly unstable or coordinate expression of the oncogene and selectable marker gene could not be obtained (Varmus et al., 1981 ; Chen & Temin, 1982; Joyner & Bernstein, 1983 b) . Insertion of the marker gene in the region that functions as an intron for the mRNA of the oncogene often inhibits expression of the transforming gene.
The neoR-MPSV vector was, however, able to transmit and express both the mos oncogene and the neo R gene on transfection and following viral infection. More than 500 independently isolated cell lines, selected either by their transformed phenotype or by G418 resistance after viral transfer, proved to express both transduced genes. These results indicate that not only can MPSV be used as a neoR-transducing retrovirus vector, but inclusion of the selectable gene into the genome does not disrupt mos expression. It has been postulated that the mos gene in the Mo-MSV genome is expressed via splicing, utilizing the env splice acceptor sites 5' to the mos gene (Weiss et al., 1982; Nash et al., 1984) . Although recent work has also indicated the importance of intron sequences in the pol gene for sufficient splicing of env in Mo-MuLV , the varying pol deletions found to date in Mo-MSV variants (Weiss et al., 1982; Kollek et al., 1984) seem to indicate that sufficient mos expression is independent of some rearrangements and deletions in the intron sequences. Alternatively, some reports suggest that the transcription of the mos gene in the Mo-MSV genome is initiated by its own promoter and enhanced by sequences in the 3' LTR (Narayanan et al., 1984) . If a similar promoter is used for expression of mos in the MPSV genome, the enhancement of mos transcription would not be affected by the insertion of the neo R gene 5' to the putative promoter.
Earlier work has shown that MPSV is an exceptional member of the Mo-MSV family in having a dual transforming potential in both fibroblasts and cells of the haematopoietic compartment Ostertag & Pragnell, 1982) , due to unique properties of the MPSV LTR that have altered the target cell specificity (Stocking et al., 1985) . MPSV, as compared to the conventional Mo-MSV and to Mo-MuLV, could possibly confer the advantage of an increased target cell range, as compared to vectors using Mo-MuLV or Mo-MSV LTRs, and hence expression of the transduced gene in a wider range of cell types. The neoR-MPSV virus not only transforms fibroblasts as efficiently as the wild-type virus (see above), but also causes leukaemogenic transformation in adult mice as shown by spleen focus formation (Table  4) , spleen enlargement, induction of anaemia, and myeloproliferation (data not shown). The delayed onset of leukaemic symptoms after infection with neoR-MPSV into mice is at present unexplained, although it could reflect a somewhat lower expression of mos not discernible with Northern analysis. Virus derived from leukaemic animals was similarly stable and segregation had not occurred, indicating that loss or alteration of the neo R function is not necessary for induction of leukaemogenesis. Moreover, infection of haematopoietic stem cell cultures by neo R-MPSV and selection of neoR-resistant colonies shows release of intact transforming virus in all of 30 such colonies which were screened (G. Johnson & W. Ostertag, unpublished) .
We have described in this work a dominant selectable retrovirus vector facilitating the study of the mos oncogene in haematopoietic differentiation and mouse development. Unlike other vonc genes, which have accumulated mutations making the oncogenes divergent from the original c-onc genes (Weiss et al., 1982) , v-mos and c-mos are interchangeable in their transformation potential (Blair et al., 1981 ; Stocking et al., 1985) . Deletion and temperature-sensitive mutants of MPSV Ostertag et al., 1984; Stocking et al., 1985) can be utilized together with the neo R marker gene to define further the role of the mos oncogene. Use of psi-2 cells or of similar cell lines (Mann et al., 1983) would eliminate the problems inherent in utilization of helper virus during transfer.
